Martins, Paulo J F <br/><br/>
Central nervous system delivery of the antipsychotic olanzapine induces hepatic insulin resistance.  [electronic resource] 

 -  Diabetes  Oct 2010 
 - 2418-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1939-327X 
<br/><br/><label>Standard No.: </label>10.2337/db10-0449  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antipsychotic Agents--administration & dosage<br/>Benzodiazepines--administration & dosage<br/>Blood Glucose--drug effects<br/>Carotid Arteries--physiopathology<br/>DNA Primers<br/>Glucose Clamp Technique<br/>Glucose-6-Phosphatase--drug effects<br/>Hyperinsulinism--physiopathology<br/>Infusions, Intravenous<br/>Injections, Intraventricular<br/>Insulin Resistance--physiology<br/>Intracellular Signaling Peptides and Proteins--drug effects<br/>Jugular Veins--physiopathology<br/>Kinetics<br/>Liver--drug effects<br/>Male<br/>Neuropeptides--drug effects<br/>Olanzapine<br/>Orexins<br/>Pro-Opiomelanocortin--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Tubulin--drug effects